Many patients with type 2 diabetes in the United States may be discouraged from taking metformin—a proven, oral diabetes medicine—because the U.S. Food and Drug Administration inappropriately labels the ...
(HealthDay)—Viral infections can happen at any time, but they're more common during winter when people spend more time in close contact with others indoors.
Patients facing limited options for treating their relapsing multiple sclerosis are celebrating the FDA's approval of a new aggressive drug treatment. The ruling reverses the agency's decision a year ago that the drug was ...
The U.S. Food and Drug Administration is building a legal case against companies that sell pure powdered caffeine, which can be fatal even in small doses.
(HealthDay)—Rapivab (peramivir) has been approved by the U.S. Food and Drug Administration to treat influenza.
Want to know how many calories are in that alcoholic drink you're about to order? You might be able to find out just by reading the menu.
(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.
Don't want to be confronted with the number of calories in that margarita or craft beer? Then avoid the menu and order at the bar.
(HealthDay)—The first test to screen for Severe Combined Immunodeficiency (SCID) in newborns has been approved by the U.S. Food and Drug Administration.
(HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and ...
The parents of an Ohio teen who died from an overdose of caffeine powder are urging federal regulators to ban sales of the stimulant, saying that children must be protected from a highly potent substance.
A panel of experts convened by US health regulators failed Wednesday to recommend whether a lifetime ban should be lifted on gay men donating blood, following two days of heated deliberations.
(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.
(HealthDay)—Most babies and young children don't need medicines if they have a cold, the U.S. Food and Drug Administration says.
U.S. regulators have declined to approve Bristol-Myers Squibb's daclatasvir as part of a combination hepatitis C treatment with another antiviral drug called asunaprevir.